In a prospective study (M Wod et al. Clin Gastroenterol Hepatol 2018; 16: 681-89), data on middle-aged (n=2346, 46-67 yrs) and older individuals (n=2475) were collected in the Longitudinal Study of Aging Danish Twins. This study showed that there was no difference in cognitive decline between PPI users and non-users.
The second study (SN Landi et al. Gastroenterol 2018; 154: 861-73) used a large administrative database and reviewed more than 5 million new users of prescription PPIs and prescription H2RAs. The authors found no significant difference in myocardial infarctions (MIs) between PPIs and H2RAs over a 12 month period.
Related blog posts:
- Recent Study DID NOT Find Dementia Risk with PPIs
- AGA Blog: What are the complications of PPI Therapy?
- Proton Pump Inhibitors Webinar
- Piling on PPIs -Now Concerns about Dementia
- Proton Pump Inhibitors Webinar
- More advice on Proton Pump Inhibitors
- The Prosecution Rests…PPIs on Trial
- PPIs Alter the Microbiome
gutsandgrowth 
Will social media pick up on this hot topic!!…..maybe something with a positive spin!!
Pingback: More Good News for PPIs: NO Increased Risk of Dementia | gutsandgrowth